Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily
Soleno Therapeutics (SLNO) Ownership Overview
17.78% Insiders
10.06% Mutual Funds
12.19% Other Institutional Investors
8.71% ETFs
51.26% Public Companies and
Individual Investors
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 30.96% of the company’s stock is owned by Institutional Investors, 17.78% is owned by Insiders, and 51.26% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 03, 2024 | Patricia C Hirano Svp, Regulatory Affairs | xxxxxxxxxxxxx | $153608 |
| Oct 03, 2024 | Anish Bhatnagar Ceo,director | xxxxxxxxxxxxx | $1069176 |
| Oct 03, 2024 | Kristen Yen Svp, Clinical Operations | xxxxxxxxxxxxx | $153608 |
| Oct 03, 2024 | xxxxxxxxxxxxx | $399193 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $4488000 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $5920488 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $13023564 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $130763020 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,291,851 | Insider | 14.59% | 372,351,742 | |
| 3,204,976 | Institution | 7.43% | 189,670,480 | |
| 1,485,992 | Institution | 3.45% | 87,941,007 | |
| 1,255,789 | Institution | 2.91% | 74,317,593 | |
| 1,241,712 | Institution | 2.88% | 73,484,516 | |
| 920,824 | Institution | 2.14% | 54,494,364 | |
| 719,553 | Insider | 1.67% | 42,583,147 | |
| 669,509 | Institution | 1.55% | 39,621,543 | |
| 326,387 | Institution | 0.76% | 19,315,583 | |
| 319,205 | Institution | 0.74% | 18,890,552 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,255,789 | Institution | 2.91% | 74,317,593 | |
| 1,241,712 | Institution | 2.88% | 73,484,516 | |
| 300,000 | Institution | 0.70% | 17,754,000 | |
| 234,730 | Institution | 0.54% | 13,891,321 | |
| 215,106 | Institution | 0.50% | 12,729,973 | |
| 170,500 | Institution | 0.40% | 10,090,190 | |
| 168,265 | Institution | 0.39% | 9,957,923 | |
| 141,888 | Institution | 0.33% | 8,396,932 | |
| 111,756 | Institution | 0.26% | 6,613,720 | |
| 97,066 | Institution | 0.23% | 5,744,366 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 913,592 | Institution | 2.12% | 46,127,260 | |
| 634,655 | Institution | 1.47% | 37,558,883 | |
| 636,436 | Institution | 1.48% | 36,308,674 | |
| 364,608 | Institution | 0.85% | 18,409,058 | |
| 254,026 | Institution | 0.59% | 15,033,259 | |
| 207,287 | Institution | 0.48% | 12,267,245 | |
| 115,230 | Institution | 0.27% | 6,573,872 | |
| 105,752 | Institution | 0.25% | 5,339,418 | |
| 70,432 | Institution | 0.16% | 4,168,166 | |
| 61,473 | Institution | 0.14% | 3,103,772 |
FAQ
Who Owns Soleno Therapeutics Inc (SLNO)?
According to the latest TipRanks data, approximately 12.19% of the company's stock is held by institutional investors, 17.78% is held by insiders, and 51.26% is held by retail investors.
What percentage of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.19% of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors.
What percentage of Soleno Therapeutics Inc (SLNO) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.26% of Soleno Therapeutics Inc (SLNO) stock is held by retail investors.
Who owns the most shares of Soleno Therapeutics Inc (SLNO)?
Vivo Opportunity, LLC owns the most shares of Soleno Therapeutics Inc (SLNO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.